|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Surveillance needed for potential recurrence of cancer: Semi-annual PSA until 5 years post-op, then annual PSA; annual digital rectal exam Surveillance needed for second malignancies: None Physicians responsible for monitoring of toxicity, recurrence, second malignancies: Dr. Smith will be following Mr. Doe for recurrence and will also assess treatment side effects. Identified psychosocial issues or concerns: Short-term depression following surgery, resolved with counseling and support group. Assess psychosocial distress during follow-up visits. Recommended preventive behaviors, interventions, or genetic testing: Patient counseled regarding diet/exercise (avoidance of obesity). At follow-up visits assess sexual function and depression. Patient given NCI booklet, Life After Cancer Treatment, and the NCCS “Cancer Survival Toolbox: An Audio Resource Program” that address medical and psychosocial issues, including those related to health insurance and employment. NOTE: All individual and hospital names are fictitious. SOURCE: Mark Litwin, committee member, 2005. Example of an End-of-Treatment Consultation Note: Colorectal CancerDate of note: April 18, 2005 Name: John Smith Age: 70 Date of tissue diagnosis of cancer: September 15, 2004 Diagnosis: Colon cancer Stage of cancer: T3N2M0 (IIIB) Pathologic findings: Moderately differentiated adenocarcinoma penetrating through the muscularis propria. No lymphovascular or perineural invasion. 5/13 regional lymph nodes positive for cancer. Initial treatment plan:
|
|
|||||||||||||||
